1037P Tumour mutational burden and HLA diversity by TruSight oncology 500 (TSO500) next generation sequencing panel and clinical outcome in non-small cell lung cancer.

Saved in:
Bibliographic Details
Title: 1037P Tumour mutational burden and HLA diversity by TruSight oncology 500 (TSO500) next generation sequencing panel and clinical outcome in non-small cell lung cancer.
Authors: Cuppens, K.1 (AUTHOR), Froyen, G.2 (AUTHOR), Cruys, B.2 (AUTHOR), Geerdens, E.2 (AUTHOR), Zhang, S.3 (AUTHOR), Zhang, B.3 (AUTHOR), Decoster, L.4 (AUTHOR), Thomeer, M.5 (AUTHOR), Maes, B.2 (AUTHOR)
Source: Annals of Oncology. 2020 Supplement 4, Vol. 31, pS713-S714. 2p.
Database: Academic Search Ultimate
Description
ISSN:09237534
DOI:10.1016/j.annonc.2020.08.1157